Abstract

Objective
  The underway airman think analyzed feasibility, venture and power of 1) microsurgery nonnegative stereotactic iodine-125 (125I) brachytherapy (SBT) for super (diameter > 4 cm), circumscribed, and Byzantine settled WHO evaluate II glioma and 2) SBT alone
for diminutive (diameter < 4 cm), and Byzantine settled recurrences.

Methods
  Lowactivity temporary 125I seeds were used. The practical meaning pane was 54 Gy and the pane evaluate was baritone (median, 10 cGy/h). Time to progression
and instance to added outside shine irradiation (EBR) and/or chemotherapy were estimated with the Kaplan-Meier method. Any
inauspicious supplement potentially imputable to communication was categorised as morbidity. Treatment personalty of SBT were estimated
according to the restricted MacDonald criteria.

Results
  Thirtyone patients (de novo group: n = 18, repetition group: n = 13) were included. The norm growth intensity before surgery
was 66 ml. A designed coloured growth resection achieved eligibility for SBT in every patients. Transient rate of microsurgery
and SBT was 27.8 % and 6.4 %, respectively. There was no imperishable morbidity. Radiogenic complications did not occur. Complete
response, coloured response, and steady disease were seen in 8, 9, and 14 patients, respectively. Ten patients exhibited tumor
advancement (overall 5-year progression- liberated activity > 60 %). The 5-year quantity to obtain chemotherapy and/or EBR
was 18 %.

Conclusion
  A designed coloured growth resection of super and Byzantine settled WHO evaluate II glioma is safe. SBT of diminutive and Byzantine located
matter of continual tumors is innocuous and minimally invasive. Combined communication haw wage the existence to keep EBR
and/or chemotherapy for a goodish sort of patients and deserves boost likely evaluation.

Content Type Journal ArticleCategory Original CommunicationDOI 10.1007/s00415-008-0948-xAuthors
O. Schnell, Ludwig-Maximilians-Universität München Dept. of Neurosurgery, Klinikum Grosshadern Marchioninistrasse 15 81377 city GermanyK. Schöller, Ludwig-Maximilians-Universität München Dept. of Neurosurgery, Klinikum Grosshadern Marchioninistrasse 15 81377 city GermanyM. Ruge, Ludwig-Maximilians-Universität München Dept. of Neurosurgery, Klinikum Grosshadern Marchioninistrasse 15 81377 city GermanyA. Siefert, Klinikum Grosshadern, Ludwig-Maximilians-Universität München Dept. of Radiotherapy and Radiation, Oncology Marchioninistrasse 15 81377 city GermanyJ. -C. Tonn, Ludwig-Maximilians-Universität München Dept. of Neurosurgery, Klinikum Grosshadern Marchioninistrasse 15 81377 city GermanyF. W. Kreth, Ludwig-Maximilians-Universität München Dept. of Neurosurgery, Klinikum Grosshadern Marchioninistrasse 15 81377 city Germany

Journal Journal of NeurologyOnline ISSN 1432-1459Print ISSN 0340-5354 (Source: Journal of Neurology)

Tags: ATM, chemotherapy, Current, Feasibility, glioma, Risk, surgery